phosphatidylinositol-4-phosphate 5-kinase type 1 beta
RGD ID:
1310914
Description:
Predicted to enable 1-phosphatidylinositol-4-phosphate 5-kinase activity. Predicted to be involved in phosphatidylinositol phosphate biosynthetic process. Predicted to act upstream of or within phosphatidylinositol biosynthetic process. Predicted to be located in cytosol and uropod. Predicted to be active in plasma membrane. Orthologous to human PIP5K1B (phosphatidylinositol-4-phosphate 5-kinase type 1 beta); PARTICIPATES IN Wnt signaling, canonical pathway; endocytosis pathway; Fc gamma receptor mediated signaling pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 6-propyl-2-thiouracil; all-trans-retinoic acid.
[Estradiol co-treated with Progesterone] results in increased expression of PIP5K1B mRNA and [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PIP5K1B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of PIP5K1B gene] and fucoxanthin inhibits the reaction [Glucose results in increased expression of PIP5K1B mRNA]
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of PIP5K1B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of PIP5K1B gene] and fucoxanthin inhibits the reaction [Glucose results in increased expression of PIP5K1B mRNA]
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of PIP5K1B mRNA
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of PIP5K1B gene] and fucoxanthin inhibits the reaction [Glucose results in increased expression of PIP5K1B mRNA]
fucoxanthin inhibits the reaction [Glucose results in decreased methylation of PIP5K1B gene] and fucoxanthin inhibits the reaction [Glucose results in increased expression of PIP5K1B mRNA]
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of PIP5K1B mRNA
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of PIP5K1B mRNA
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIP5K1B mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIP5K1B mRNA
